⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13040601 | 0.71 | — | — | |
| SCHEMBL9815660 | 0.71 | — | — | |
| SCHEMBL11714549 | 0.63 | — | — | |
| SCHEMBL10536753 | 0.58 | — | — | |
| SCHEMBL20346416 | 0.56 | — | — | |
| SCHEMBL328889 | 0.56 | LMNA (0.33) | — | |
| SCHEMBL16789911 | 0.56 | — | — | |
| SCHEMBL20909801 | 0.56 | — | — | |
| SCHEMBL10097032 | 0.56 | — | — | |
| SCHEMBL19568204 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016165613-A1 | HETEROCYCLES USEFUL AS IDO AND TDO INHIBITORS | HANGZHOU INNOGATE PHARMA CO., LTD. (CN) | 2016-10-20 | — | — | WO | disclosed |